NASDAQ:AMIX Autonomix Medical (AMIX) Stock Price, News & Analysis → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free AMIX Stock Alerts $3.32 -0.04 (-1.19%) (As of 04/29/2024 ET) Add Compare Share Share Today's Range$3.31▼$3.7950-Day Range$2.66▼$4.4352-Week Range$2.50▼$7.60Volume18,180 shsAverage Volume62,552 shsMarket Capitalization$62.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial Media Get Autonomix Medical alerts: Email Address Ad Banyan Hill PublishingNvidia CEO Says It Will Be “the Next Revolution” Beyond AINvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. About Autonomix Medical Stock (NASDAQ:AMIX)Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.Read More AMIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AMIX Stock News HeadlinesApril 25, 2024 | finance.yahoo.comAutonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary MicrochipApril 24, 2024 | globenewswire.comAutonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment WebinarApril 29, 2024 | Unstoppable Prosperity (Ad)Charles Payne’s Gift to Stock InvestorsRight now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.April 20, 2024 | americanbankingnews.comAutonomix Medical (NASDAQ:AMIX) Stock Price Up 5.2%April 16, 2024 | globenewswire.comAutonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related PainApril 15, 2024 | finance.yahoo.comAutonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 11, 2024 | benzinga.comAutonomix Medical (NASDAQ: AMIX) Is Cracking the Code Of The Peripheral Nervous System With Its Breakthrough Technology To Treat DiseasesApril 11, 2024 | uk.investing.comAutonomix Medical's study shows promise in renal treatmentApril 29, 2024 | Unstoppable Prosperity (Ad)Charles Payne’s Gift to Stock InvestorsRight now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.April 9, 2024 | globenewswire.comAutonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal DenervationApril 8, 2024 | globenewswire.comAutonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX TickerMarch 27, 2024 | globenewswire.comAutonomix to Present at the MedInvest Biotech & Pharma Investor ConferenceMarch 21, 2024 | uk.investing.comAutonomix Medical hires new Chief Business OfficerMarch 20, 2024 | globenewswire.comAutonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024March 19, 2024 | globenewswire.comAutonomix Appoints Jennifer Cook as Chief Business OfficerMarch 15, 2024 | marketwatch.comAutonomix Medical Shares Rise on First Three Patient Procedures CompletionMarch 14, 2024 | globenewswire.comAutonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer MarketMarch 6, 2024 | globenewswire.comAutonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer MarketMarch 1, 2024 | uk.investing.comAutonomix Medical Inc (AMIX)February 29, 2024 | globenewswire.comAutonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical TrialFebruary 23, 2024 | globenewswire.comAutonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix OpportunityFebruary 22, 2024 | finance.yahoo.comAutonomix Secures Principal Investigators and Completes Clinical Training for First Human StudyFebruary 21, 2024 | morningstar.comAutonomix Medical Inc AMIXFebruary 16, 2024 | globenewswire.comAutonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer MarketFebruary 14, 2024 | globenewswire.comAutonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key MilestonesSee More Headlines Receive AMIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Autonomix Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/13/2024Today4/29/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:AMIX Previous SymbolNASDAQ:AMIX CUSIPN/A CIK1617867 Webautonomix.com Phone713-588-6150FaxN/AEmployees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.73 Quick Ratio1.73 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.29) per share Price / Book-12.76Miscellaneous Outstanding Shares18,790,000Free FloatN/AMarket Cap$69.52 million OptionableN/A BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Walter V. Klemp (Age 64)Executive Chairman Comp: $200kDr. Robert Schwartz M.D. (Age 72)Co-Founder & Chief Medical Officer Comp: $100kMr. Landy Toth (Age 46)Co-Founder & Chief Technology Officer Comp: $156.25kMs. Lori H. Bisson (Age 52)CEO & Director Mr. Trent N. Smith CPA (Age 55)Chief Financial Officer Ms. Jennifer CookChief Business OfficerMore ExecutivesKey CompetitorsPro-DexNASDAQ:PDEXSEP AcquisitionNASDAQ:SEPAenVVeno MedicalNASDAQ:NVNOSensus HealthcareNASDAQ:SRTSIceCure MedicalNASDAQ:ICCMView All Competitors AMIX Stock Analysis - Frequently Asked Questions How have AMIX shares performed in 2024? Autonomix Medical's stock was trading at $5.20 on January 1st, 2024. Since then, AMIX shares have decreased by 36.2% and is now trading at $3.32. View the best growth stocks for 2024 here. When is Autonomix Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our AMIX earnings forecast. How were Autonomix Medical's earnings last quarter? Autonomix Medical, Inc. (NASDAQ:AMIX) issued its earnings results on Tuesday, February, 13th. The company reported ($0.23) earnings per share for the quarter. When did Autonomix Medical IPO? Autonomix Medical (AMIX) raised $11 million in an IPO on the week of January 29th 2024. The company issued 2,234,222 shares at $5.00 per share. When did the company's quiet period expire? Autonomix Medical's quiet period expired on Monday, March 11th. Autonomix Medical had issued 2,234,222 shares in its public offering on January 29th. The total size of the offering was $11,171,110 based on an initial share price of $5.00. During the company's quiet period, underwriters and any insiders that worked on the IPO were restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company. How do I buy shares of Autonomix Medical? Shares of AMIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:AMIX) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsNvidia CEO Says It Will Be “the Next Revolution” Beyond AIBanyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autonomix Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
